avian
paramyxovirus
apmv
serotyp
frequent
isol
domest
wild
bird
worldwid
also
call
newcastl
diseas
viru
ndv
attenu
nonhuman
primat
develop
candid
human
vaccin
vector
vector
potenti
serotyp
unknown
present
studi
evalu
nine
differ
biologicallyor
recombinantlyderiv
apmv
strain
abil
replic
caus
diseas
rhesu
macaqu
model
five
virus
biologicallyderiv
wild
type
wt
anoth
viru
recombin
r
version
wt
remain
three
virus
version
wt
f
cleavag
site
modifi
multibas
rhesu
macaqu
inocul
intranas
intratrach
monitor
clinic
diseas
viru
shed
upper
lower
respiratori
tract
seroconvers
viru
shed
detect
wt
limit
shed
detect
wt
modifi
subset
anim
shed
virus
detect
everi
infect
anim
usual
upper
lower
respiratori
tract
particular
shed
number
day
everi
anim
observ
modifi
wt
modifi
modif
f
protein
cleavag
site
appear
increas
shed
wt
margin
wt
apmv
except
wt
induc
virusspecif
serum
antibodi
respons
infect
anim
none
anim
exhibit
clinic
diseas
sign
result
indic
apmv
compet
infect
nonhuman
primat
moderatelytohighli
restrict
depend
serotyp
suggest
like
significantli
infect
primat
natur
repres
promis
attenu
candid
vector
develop
avian
paramyxovirus
apmv
isol
wild
domest
bird
world
apmv
divid
nine
serotyp
apmv
base
hemagglutin
inhibit
hi
neuraminidas
inhibit
ni
assay
recent
virus
repres
potenti
apmv
serotyp
isol
rockhopp
penguin
common
teal
respect
includ
strain
newcastl
diseas
viru
ndv
extens
character
virul
ndv
strain
caus
sever
diseas
chicken
ndv
strain
divid
three
pathotyp
base
virul
chicken
highli
virul
velogen
strain
caus
sever
respiratori
neurolog
diseas
moder
virul
mesogen
strain
caus
milder
diseas
nonpathogen
lentogen
strain
caus
inappar
infect
mesogen
lentogen
strain
ndv
highli
restrict
replic
highli
attenu
nonavian
speci
includ
primat
develop
vaccin
vector
anim
human
pathogen
previou
studi
shown
apmv
serotyp
replic
avian
speci
also
mice
hamster
howev
abil
replic
possibl
caus
diseas
primat
potenti
human
vaccin
vector
unknown
apmv
belong
famili
paramyxovirida
larg
divers
famili
includ
virus
wide
varieti
mammalian
avian
reptilian
fish
speci
around
world
member
famili
respons
major
human
anim
diseas
other
caus
inappar
infect
paramyxovirus
pleomorph
envelop
contain
nonseg
negativesens
singlestrand
rna
genom
kb
basi
viru
structur
genom
organ
sequenc
related
famili
paramyxovirida
divid
two
subfamili
paramyxovirina
pneumovirina
subfamili
paramyxovirina
divid
five
genera
respiroviru
includ
sendai
viru
human
parainfluenza
viru
type
rubulaviru
includ
parainfluenza
viru
previous
known
simian
viru
type
mump
viru
human
parainfluenza
viru
type
morbilliviru
includ
measl
canin
distemp
virus
henipaviru
compris
hendra
nipah
virus
avulaviru
compris
apmv
subfamili
pneumovirina
contain
two
genera
pneumoviru
includ
human
bovin
respiratori
syncyti
virus
metapneumoviru
compris
human
metapneumoviru
avian
metapneumovirus
although
lot
inform
avail
much
less
known
molecular
biolog
pathogen
host
rang
apmv
serotyp
initi
step
toward
character
recent
determin
complet
genom
sequenc
develop
revers
genet
system
howev
biolog
characterist
pathogen
remain
poorli
understood
associ
sever
respiratori
diseas
reduc
egg
product
infertil
turkey
associ
enceph
high
mortal
cage
bird
respiratori
diseas
turkey
stunt
growth
young
chicken
strain
isol
chicken
duck
gees
caus
diseas
budgerigar
character
depress
dyspnoea
diarrhea
high
mortal
caus
mild
respiratori
diseas
turkey
associ
drop
egg
product
isol
duck
waterfowl
wild
bird
produc
clinic
sign
viral
infect
chicken
last
year
revers
genet
techniqu
made
possibl
engin
ndv
potenti
vaccin
vector
human
anim
use
ndv
vector
express
number
foreign
antigen
evalu
avian
host
also
murin
nonhuman
primat
model
sever
strain
ndv
shown
highli
restrict
replic
mammalian
model
indic
highli
attenu
due
strong
host
rang
restrict
repres
promis
vaccin
vector
howev
ndv
strain
highli
relat
antigen
therefor
use
ndv
vector
multipl
purpos
would
compromis
induct
vectorspecif
immun
limit
might
overcom
use
apmv
serotyp
antigen
distinct
ndv
altern
vaccin
vector
addit
possibl
one
apmv
serotyp
might
advantag
properti
predict
increas
immunogen
compar
ndv
furthermor
possibl
exist
one
apmv
serotyp
might
pathogen
certain
nonavian
host
includ
primat
exampl
viru
previous
recov
cynomolgu
monkey
respiratori
diseas
viru
recov
pig
therefor
evalu
nonavian
speci
warrant
recent
show
compet
infect
replic
lowtomoder
titer
mice
hamster
howev
rodent
uncertain
predictor
perform
speci
human
possibl
inde
like
differ
level
host
rang
restrict
rodent
speci
includ
primat
present
studi
sought
evalu
replic
pathogen
rhesu
macaqu
surrog
human
virus
includ
biologicallyand
recombinantlyderiv
wt
virus
well
sever
recombin
virus
f
protein
cleavag
site
modifi
multibas
contain
optim
furin
proteas
cleavag
site
motif
rx
rk
rq
signatur
r
k
residu
underlin
done
presenc
furin
motif
f
protein
cleavag
site
typic
facilit
cleavag
major
determin
virul
ndv
strain
although
paradigm
uncertain
apmv
serotyp
present
studi
show
except
apmv
evalu
replic
vari
level
rhesu
macaqu
without
induc
appar
clinic
diseas
sign
thu
apmv
serotyp
infecti
replicationcompet
attenu
nonhuman
primat
futur
work
revers
genet
system
use
develop
apmv
vector
vaccin
adult
rhesu
macaqu
macaca
mullatta
obtain
niaid
breed
coloni
locat
morgan
island
sc
coloni
aaalac
intern
accredit
olaw
assur
anim
transport
accord
usda
guidelin
permit
nonhuman
primat
experi
perform
site
approv
associ
assess
accredit
laboratori
anim
care
intern
protocol
approv
anim
care
use
committe
nation
institut
allergi
infecti
diseas
sinc
studi
involv
infecti
agent
rhesu
macaqu
hous
individu
microisol
cage
durat
studi
necessari
prevent
transmiss
respiratori
virus
nonhuman
primat
room
anim
handler
monkey
abl
see
monkey
speci
monkey
environment
enrich
program
addit
object
manipul
perch
food
enrich
anim
observ
least
two
time
day
anim
care
staff
ill
abnorm
anim
sacrif
studi
experi
old
embryon
chicken
egg
use
end
day
collect
allanto
fluid
egg
embryo
sacrif
incub
egg
refriger
hour
chicken
embryo
fibroblast
african
green
monkey
kidney
vero
cell
line
obtain
american
type
cultur
collect
atcc
manassa
va
grown
dulbecco
modifi
eagl
medium
dmem
contain
fetal
bovin
serum
fb
maintain
dmem
fb
nine
apmv
strain
use
studi
see
tabl
construct
previou
work
biologicallyderiv
wt
strain
ii
recombin
deriv
wt
call
type
africa
natur
cleavag
site
replac
cleavag
site
rrrrrqf
present
apmv
type
strain
isol
africa
iii
biologicallyderiv
wt
strain
iv
recombin
wt
strain
duckhong
v
deriv
call
natur
cleavag
site
replac
cleavag
site
rrqkrqf
present
mesogen
ndv
strain
baudett
c
vi
biologicallyderiv
wt
strain
vii
biologicallyderiv
wt
strain
viii
recombin
deriv
wt
call
natur
cleavag
site
replac
cleavag
site
rrkkrqfi
present
velogen
ndv
strain
includ
amino
acid
substitut
posit
rel
cleavag
site
ix
biologicallyderiv
wt
strain
ducknew
apmv
serotyp
except
serotyp
grown
allanto
caviti
specificpathogenfre
spf
embryon
chicken
egg
grown
vero
cell
allanto
fluid
infect
egg
collect
h
postinocul
viru
titer
determin
hemagglutin
ha
assay
titer
apmv
determin
plaqu
assay
cell
vero
cell
sampl
inocul
triplic
onto
plate
vero
cell
confluenc
viru
titer
determin
either
plaqu
assay
immunostain
n
specif
antibodi
adult
rhesu
macaqu
macaca
mulatta
obtain
morgan
island
anim
confirm
seroneg
apmv
serotyp
hemagglutin
inhibit
hi
plaqu
reduct
assay
rhesu
macaqu
anim
per
viru
infect
combin
intranas
intratrach
rout
use
ml
inoculum
per
site
contain
pfu
per
ml
indic
viru
describ
previous
nasal
wash
mlanim
fecal
swab
mlanim
collect
daili
day
phosphat
buffer
salin
pb
bronchoalveolar
lavag
bal
mlanim
collect
day
pb
tracheal
lavag
ml
anim
collect
day
pb
sampl
snapfrozen
dri
ice
store
c
analyz
serum
sampl
obtain
day
clinic
observ
perform
daili
day
inocul
nasal
wash
bal
tracheal
lavag
fecal
sampl
monkey
clarifi
centrifug
supernat
collect
clarifi
sampl
dilut
serial
dilut
pb
dilut
ml
inocul
triplic
allanto
caviti
embryon
chicken
egg
egg
incub
day
allanto
fluid
collect
egg
presenc
viru
detect
hemagglutin
ha
test
chicken
rbc
percent
egg
infecti
dose
eid
viru
titer
express
log
eid
per
ml
determin
method
reed
muench
replic
rhesu
monkey
determin
titrat
vero
cell
follow
neuramindas
na
assay
describ
huang
et
al
serum
antibodi
level
specif
apmv
serotyp
use
immun
evalu
preand
postimmun
hemagglutin
inhibit
hi
assay
viru
neutral
vn
assay
western
blot
analysi
except
serum
antibodi
respons
evalu
vn
neuraminidas
inhibit
nai
assay
hi
assay
ml
serum
sampl
first
treat
ml
receptor
destroy
enzym
ii
catalog
number
ycc
accur
chemic
scientif
westburi
ny
ratio
volvol
overnight
ml
sodium
citrat
ad
incub
continu
min
serum
sampl
allow
cool
room
temperatur
ml
pack
chicken
rbc
ad
incub
min
sampl
centrifug
g
min
supernat
use
hi
assay
hi
assay
twofold
serial
dilut
treat
sera
ml
prepar
dilut
combin
ha
unit
particular
live
homolog
apmv
serotyp
follow
h
incub
ml
chicken
rbc
ad
incub
min
room
temperatur
ha
score
mean
reciproc
log
standard
error
mean
highest
serum
dilut
caus
complet
inhibit
four
ha
unit
indic
apmv
case
antibodi
titer
measur
nai
assay
nai
assay
strain
budgerigarkunitachi
use
sourc
na
na
activ
measur
modifi
fluorometr
assay
briefli
serial
twofold
dilut
serum
sampl
prepar
ml
volum
enzym
buffer
mm
ethanesulfon
acid
me
ph
mm
calcium
chlorid
plate
ml
dilut
enzym
buffer
constant
na
amount
optic
densiti
nm
od
ad
sourc
na
incub
h
room
temperatur
ten
microlit
volvol
dimethyl
sulfoxid
ad
well
fluorometr
assay
plate
black
plate
microfluor
franklin
ten
microlit
serum
viru
mixtur
transfer
duplic
assay
plate
ml
dilut
viru
enzym
buffer
alon
use
posit
neg
control
respect
reaction
initi
addit
ml
substrat
mix
volum
mm
me
ph
volum
mm
calcium
chlorid
volum
mm
adnacetylneuramin
acid
mun
sigma
give
final
concentr
mm
mun
assay
reaction
mixtur
incub
min
shake
reaction
termin
addit
ml
termin
buffer
sodium
hydroxid
volvol
ethanol
extent
reaction
quantifi
fluorometri
excit
wavelength
nm
emiss
wavelength
nm
use
multilabel
plate
reader
perkinelm
read
substrat
blank
subtract
viru
sampl
read
averag
backgroundcorrect
na
activ
calcul
independ
well
neuraminidas
inhibit
nai
titer
sampl
report
reciproc
log
highest
serum
dilut
result
greater
reduct
input
na
activ
neutral
antibodi
titer
postimmun
sera
collect
day
rhesu
macaqu
measur
microneutr
assay
briefli
serial
dilut
ml
heatinactiv
monkey
serum
sampl
mix
tcid
homolog
apmv
serotyp
incub
h
follow
incub
ml
volum
virusserum
mixtur
serum
dilut
ad
approxim
ml
medium
quadrupl
well
vero
cell
plate
plate
incub
h
score
viru
replic
base
ha
activ
supernat
titer
defin
mean
reciproc
log
highest
serum
dilut
result
complet
neutral
infect
well
sera
infect
rhesu
monkey
assay
apmvspecif
antibodi
western
blot
partial
purifi
apmv
mg
per
lane
subject
sdspage
reduc
condit
transfer
nitrocellulos
membran
membran
strip
incub
dilut
day
day
serum
sampl
individu
monkey
group
follow
incub
dilut
hrpconjug
goat
antihuman
igg
fab
specif
hemagglutinin
hn
fusion
f
f
nucleocapsid
np
phophoprotein
p
matrix
protein
specif
particular
apmv
serotyp
detect
chemiluminesc
assay
adult
rhesu
macaqu
group
four
inocul
combin
intranas
intratrach
rout
pfu
per
site
nine
apmv
strain
repres
six
serotyp
name
serotyp
tabl
materi
method
five
strain
biolog
deriv
wt
virus
anoth
viru
recombin
deriv
wt
remain
three
virus
call
type
africa
version
wt
respect
naturallyoccur
nonmultibas
f
cleavag
site
modifi
multibas
site
contain
optim
furin
motif
tabl
anim
observ
daili
day
day
clinic
sign
ill
distress
none
anim
exhibit
clinic
sign
infect
weight
loss
increas
bodi
temperatur
fever
sign
respiratori
distress
death
record
thu
none
apmv
strain
cleavag
site
mutant
overtli
pathogen
rhesu
macaqu
evalu
replic
apmv
upper
respiratori
tract
rhesu
macaqu
nasal
wash
collect
day
day
viru
titer
determin
titrat
embryon
chicken
egg
except
grow
chicken
egg
thu
serial
dilut
prepar
nasal
wash
inocul
allanto
caviti
embryon
chicken
egg
dpi
allanto
fluid
collect
assay
presenc
viru
ha
assay
viru
titer
express
log
eid
per
ml
tabl
replic
determin
limit
dilut
assay
vero
cell
virusinfect
well
detect
na
activ
viru
shed
upper
respiratori
tract
undetect
strain
name
wt
wt
strain
low
level
shed
detect
anim
specif
wt
detect
nasal
wash
anim
day
anim
day
anim
day
anim
day
mean
daili
titer
rang
log
eid
per
ml
highest
mean
daili
titer
detect
day
replic
recombin
version
multibas
f
cleavag
site
deriv
serotyp
africa
detect
anim
anim
shed
low
titer
viru
consecut
day
anoth
shed
viru
day
anoth
shed
viru
day
shed
wt
detect
anim
anim
shed
day
anim
shed
detect
viru
singl
day
wt
isol
inocul
anim
day
either
anim
day
wherea
isol
day
anim
detect
anim
day
wt
detect
singl
day
day
anim
anim
shed
sever
day
evalu
replic
apmv
lower
respiratori
tract
inocul
anim
bal
collect
day
tracheal
lavag
collect
day
sampl
process
titrat
describ
viru
detect
bal
sampl
tabl
strain
except
wt
replic
detect
lower
respiratori
tract
rhesu
macaqu
specif
wt
detect
anim
day
anim
day
respect
tabl
replic
type
africa
seem
robust
viru
shed
detect
day
day
anim
mean
daili
titer
rang
log
eid
per
ml
shed
wt
detect
inocul
anim
day
anim
day
mean
daili
titer
interestingli
wt
detect
nasal
wash
anim
describ
tabl
viru
detect
day
bal
anim
tabl
similarli
f
cleavag
mutant
detect
nasal
wash
specimen
tabl
detect
day
andor
bal
inocul
anim
wherea
wt
detect
bal
day
cleavag
site
mutant
deriv
detect
day
consist
shed
wt
detect
anim
day
mean
daili
titer
virus
similar
rang
log
eid
per
ml
thu
appear
cleavag
site
mutat
neg
effect
replic
wt
upper
respiratori
tract
tabl
affect
replic
lower
respiratori
tract
tabl
version
detect
readili
lower
versu
upper
respiratori
tract
wt
detect
day
inocul
anim
anim
day
overal
comparison
viru
replic
lower
respiratori
tract
sum
daili
bal
titer
day
calcul
anim
mean
sum
daili
titer
viru
calcul
tabl
identifi
wt
wt
virus
lowest
level
replic
lower
respiratori
tract
order
wt
log
log
wt
log
wt
wt
replic
slightli
higher
overal
level
wt
log
wt
log
type
africa
wt
identifi
virus
highest
mean
sum
daili
titer
type
africa
log
wt
log
log
interestingli
mean
sum
daili
titer
f
cleavag
site
type
africa
significantli
higher
wt
show
replac
f
cleavag
site
type
africa
significantli
increas
replic
lower
respiratori
tract
one
way
anova
tukey
posthoc
analysi
summari
apmv
serotyp
deriv
thereof
f
cleavag
site
mutat
replic
rhesu
macaqu
lowtomoder
level
period
day
type
africa
wt
show
consist
replic
upper
lower
respiratori
tract
rhesu
macaqu
replic
apmv
serotyp
undetect
upper
respiratori
tract
lower
respiratori
tract
low
level
shed
close
level
detect
detect
viru
shed
detect
upper
lower
respiratori
tract
virus
day
postinfect
indic
replic
virus
selflimit
furthermor
detect
spread
apmv
gastrointestin
tract
shown
one
virus
test
name
wt
could
detect
nasal
wash
bal
inocul
anim
serum
sampl
rhesu
macaqu
infect
variou
apmv
strain
collect
day
dpi
serotypespecif
serum
antibodi
titer
determin
modifi
hi
assay
use
chicken
erythrocyt
except
case
case
titer
determin
ni
assay
vero
cell
tabl
anim
confirm
seroneg
apmvspecif
antibodi
day
apmv
serotyp
induc
serum
antibodi
respons
howev
magnitud
respons
vari
day
highest
mean
hi
antibodi
titer
observ
rhesu
macaqu
immun
wt
log
moder
mean
hi
antibodi
titer
observ
wt
wt
wt
lowest
mean
hi
antibodi
titer
observ
type
africa
wt
case
wt
two
four
anim
serum
hi
antibodi
respons
mean
hi
antibodi
titer
valu
determin
day
similar
day
valu
abil
serum
sampl
collect
day
neutral
respect
apmv
serotyp
assess
microneutr
assay
tabl
antisera
monkey
immun
wt
highest
mean
neutral
antibodi
titer
log
next
highest
titer
observ
monkey
infect
wt
neutral
antibodi
titer
monkey
infect
serotyp
decreas
order
wt
wt
wt
surprisingli
serum
neutral
antibodi
detect
case
type
africa
studi
direct
correl
found
hi
titer
neutral
titer
addit
examin
serum
sampl
collect
day
rhesu
monkey
reactiv
differ
apmv
protein
purifi
virion
egg
allanto
fluid
western
blot
assay
fig
examin
infecti
viru
recov
anim
thu
infect
minim
neg
probe
western
blot
preimmun
immun
serum
sampl
four
monkey
infect
apmv
everi
anim
react
respect
np
f
p
protein
vari
degre
intens
mg
apmv
viru
prepar
run
gel
blot
nitrocellulos
hn
f
protein
reactiv
band
recogn
vari
extent
sera
individu
anim
consist
known
drastic
chang
immun
reactiv
paramyxoviru
hn
f
protein
denatur
preimmun
serum
sampl
found
neg
apmv
frequent
isol
wide
varieti
avian
speci
around
world
group
nine
establish
serotyp
although
two
addit
serotyp
provision
identifi
introduct
among
nine
establish
serotyp
ndv
extens
character
due
import
major
pathogen
poultri
apmv
serotyp
frequent
isol
domest
wild
bird
larg
uncharacter
recent
ndv
shown
infect
avian
speci
also
nonavian
speci
although
replic
restrict
nonavian
host
ndv
develop
promis
viral
vaccin
vector
deliveri
number
antigen
anim
human
pathogen
howev
potenti
vaccin
vector
human
known
previous
demonstr
replic
hamster
mice
howev
low
phylogenet
anatom
related
rodent
model
human
necessit
use
relev
model
assess
replic
pathogen
therefor
goal
studi
evalu
replic
pathogen
number
nonndv
apmv
serotyp
nonhuman
primat
rhesu
macaqu
evalu
permiss
infect
clinic
diseas
magnitud
replic
shed
induct
antibodi
rhesu
macaqu
use
commonli
nonhuman
primat
model
studi
replic
pathogen
variou
virus
screen
attenu
phenotyp
live
viru
vaccin
evalu
immun
respons
viru
vaccin
candid
safeti
immunogen
protect
efficaci
ndv
also
demonstr
model
studi
chose
evalu
nine
differ
apmv
strain
six
wt
virus
repres
six
differ
serotyp
specif
biologicallyderiv
wt
apmv
well
recombin
version
wt
chose
wt
wt
previous
show
replic
virus
cell
cultur
requir
enhanc
exogen
proteas
supplement
sinc
properti
known
correl
pantrop
replic
virul
ndv
chicken
possibl
might
confer
increas
replic
nonndv
apmv
rhesu
macaqu
although
note
ndv
paradigm
consist
nonndv
apmv
chicken
wt
select
viru
replic
high
titer
cell
cultur
revers
genet
system
develop
serotyp
wt
select
viru
replic
well
nasal
turbin
lung
mice
hamster
three
virus
evalu
studi
recombin
version
naturallyoccur
f
protein
cleavag
site
replac
multibas
cleavag
site
contain
optim
furin
motif
specif
type
africa
contain
multibas
cleavag
site
rrrrrqf
present
virul
african
ndv
strain
contain
cleavag
site
rrqkrqf
deriv
mesogen
ndv
strain
baudett
c
contain
cleavag
site
rrkkrqf
deriv
velogen
ndv
strain
note
ndv
multibas
cleavag
site
gener
associ
greater
virul
chicken
rhesu
macaqu
infect
show
sign
diseas
replic
low
titer
upper
respiratori
tract
evidenc
low
level
shed
virus
nasal
wash
anim
day
found
neg
shed
upper
respiratori
tract
similarli
previous
show
rhesu
macaqu
african
green
monkey
infect
combin
intranas
intratrach
rout
ndv
strain
bc
mostli
neg
viral
shed
togeth
result
indic
apmv
highli
restrict
replic
upper
respiratori
tract
monkey
howev
analysi
bal
sampl
present
studi
reveal
replic
apmv
except
wt
lower
respiratori
tract
day
post
infect
although
differ
level
magnitud
shed
wt
type
africa
wt
wt
moder
case
wt
wt
low
contrast
low
level
shed
determin
plaqu
assay
tracheal
lavag
sampl
lung
tissu
detect
lower
respiratori
tract
agm
infect
ndv
earlier
studi
indic
compar
ndv
wt
recombin
wt
replic
effici
lower
respiratori
tract
nonhuman
primat
appar
increas
replic
may
provid
advantag
increas
immunogen
express
foreign
antigen
despit
somewhat
greater
replic
certain
apmv
respiratori
tract
analysi
fecal
sampl
rhesu
macaqu
infect
apmv
reveal
shed
suggest
lack
spread
gastrointestin
tract
observ
suggest
like
ndv
highli
restrict
highli
attenu
nonhuman
primat
number
apmv
strain
replic
upper
respiratori
tract
appear
less
effici
compar
lower
respiratori
tract
one
possibl
explan
might
lower
densiti
apmv
receptor
upper
respiratori
tract
nonhuman
primat
compar
lower
respiratori
tract
henc
lower
level
replic
second
possibl
factor
bird
higher
bodi
temperatur
compar
primat
therefor
upper
lower
respiratori
tract
primat
may
suboptim
apmv
replic
effect
would
pronounc
upper
respiratori
tract
due
rel
lower
temperatur
low
level
shed
apmv
upper
respiratori
tract
nonhuman
primat
predict
shed
also
reduc
human
would
limit
releas
environ
would
desir
featur
vaccin
vector
previous
show
wherea
wt
form
syncytia
plaqu
cell
cultur
despit
independ
ad
proteas
case
introduct
respect
multibas
site
result
gaininfunct
confer
abil
form
syncytia
plaqu
introduct
multibas
site
also
increas
viru
replic
vitro
case
type
africa
case
howev
observ
differ
replic
pathogen
chicken
purpos
develop
apmv
vaccin
vector
possibl
human
use
mutat
least
two
potenti
advantag
first
increas
growth
vitro
would
facilit
vaccin
manufactur
second
cleavag
site
mutat
might
increas
vector
replic
primat
case
modest
increas
replic
might
increas
immunogen
express
foreign
antigen
retain
attenu
phenotyp
present
studi
introduct
multibas
site
associ
appar
increas
replic
case
continu
experi
describ
serum
sampl
collect
inocul
day
inocul
day
hemagglutin
inhibit
hi
titer
express
mean
reciproc
log
standard
error
mean
highest
serum
dilut
caus
complet
inhibit
four
ha
unit
indic
apmv
except
evalu
neuraminidas
inhibit
ni
assay
valu
averag
three
independ
experi
mean
serum
hi
titer
day
serum
sampl
serum
neutral
antibodi
titer
express
mean
reciproc
log
serum
dilut
result
complet
neutral
infect
well
mean
standard
error
mean
limit
detect
mean
neutral
antibodi
titer
day
serum
sampl
antibodi
respons
evalu
ni
assay
describ
materi
method
ni
titer
express
mean
reciproc
log
standard
error
mean
highest
serum
dilut
caus
neuraminidas
inhibit
figur
analysi
reactiv
sera
rhesu
macaqu
collect
follow
infect
indic
apmv
evalu
western
blot
purifi
viru
homolog
apmv
strain
viru
repres
indic
apmv
strain
type
africa
possibl
margin
increas
case
appar
decreas
replic
case
respect
absenc
clinic
diseas
mutant
remain
attenu
wt
parent
howev
larger
studi
would
requir
confirm
preliminari
observ
singl
inocul
via
combin
intranas
intratrach
rout
rhesu
macaqu
wt
wt
wt
wt
induc
substanti
hi
antibodi
titer
wherea
serum
hi
antibodi
respons
induc
type
africa
wt
wt
low
hi
titer
correl
either
complet
partial
level
shed
lower
respiratori
tract
except
case
wt
shed
observ
low
level
ni
titer
produc
date
isol
budgerigar
thought
natur
host
observ
indic
viru
probabl
strongli
host
restrict
studi
direct
correl
found
hi
titer
neutral
titer
case
wt
wt
neutral
titer
higher
compar
hi
titer
wherea
convers
true
remain
apmv
sinc
hi
titer
reflect
antibodi
specif
attach
site
hn
wherea
neutral
antibodi
reflect
broader
antibodi
respons
antigen
site
throughout
hn
f
protein
instanc
rel
higher
neutral
titer
might
reflect
disproportion
greater
contribut
addit
epitop
hn
f
protein
serum
hi
antibodi
titer
induc
rhesu
monkey
wt
wt
wt
wt
either
higher
equal
hi
antibodi
titer
induc
mesogen
ndv
strain
bc
african
green
monkey
previou
studi
serotyp
thu
candid
develop
vaccin
human
use
case
wt
wt
monkey
seroconvert
type
africa
hi
antibodi
titer
lower
induc
ndv
previou
studi
suggest
serotyp
less
promis
one
incongru
present
studi
low
titer
hi
antibodi
lack
detect
neutral
antibodi
induc
type
africa
despit
rel
robust
replic
vector
compar
greater
immunogen
wt
parent
despit
lower
replic
parent
summari
evalu
replic
pathogen
apmv
nonhuman
primat
respiratori
virus
highli
restrict
replic
respiratori
tract
rhesu
macaqu
also
demonstr
substanti
level
immunogen
wt
recombin
wt
nonhuman
primat
model
apmv
serolog
distinct
ndv
may
develop
vector
use
heterolog
primeboost
combin
induc
robust
system
mucos
immun
respons
foreign
antigen
